Table 1.
Clinical Demographics and the Diagnosis of ACS
Total, n = 265 | ACS, n = 82 | Non‐ACS, n = 183 | P Valuea | |
---|---|---|---|---|
Age, y, mean (SD)/median | 63 (17)/64 | 67.8 (13.7)/70 | 61.4 (18.1)/63 | 0.0047 |
Male sex, n (%) | 151 (57) | 49 (60) | 102 (56) | 0.51 |
BMI, kg/m2, mean (SD)/median | 29.9 (9.2)/28.4 | 30.0 (8.1)/28.6 | 29.9 (9.7)/28.2 | 0.93 |
Race, n (%) | ||||
Caucasian | 215 (81) | 70 (85) | 145 (80) | 0.23 |
African American | 32 (12) | 7 (9) | 25 (14) | 0.24 |
Other | 15 (6) | 4 (5) | 11 (6) | 0.71 |
Hypertension, n (%) | 177 (66) | 61 (74) | 116 (63) | 0.066 |
Diabetes mellitus, n (%) | 89 (33) | 37 (45) | 52 (28) | 0.008 |
Hyperlipidemia, n (%) | 125 (47) | 50 (61) | 75 (41) | 0.002 |
Family history, n (%) | 77 (29) | 31 (38) | 46 (25) | 0.036 |
Tobacco history, n (%) | 146 (55) | 52 (63) | 94 (51) | 0.061 |
PVOD, n (%) | 32 (12) | 16 (20) | 16 (9) | 0.016 |
CVA, n (%) | 19 (7) | 5 (6) | 14 (8) | 0.65 |
ESRD, n (%) | 22 (8) | 7 (8) | 15 (8) | 0.92 |
CAD history, n (%) | 107 (40) | 51 (62) | 56 (30) | <0.0001 |
PCI/CABG, n (%) | 75 (28) | 38 (46) | 37 (20) | <0.0001 |
LV dysfunction, LVEF <55%, n (%) | 32 (12) | 12 (15) | 20 (11) | 0.39 |
Atrial fibrillation, n (%) | 49 (18) | 6 (7) | 43 (23) | 0.0008 |
Aortic stenosis (moderate/severe), n (%) | 14 (5) | 4 (4) | 10 (5) | 0.85 |
Abbreviations: BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CVA, cerebrovascular accident; ESRD, end‐stage renal disease; LV, left ventricular; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; PVOD, peripheral vascular occlusive disease; SD, standard deviation.
P value for between‐group comparisons.